Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of Invention Described in U.S. Provisional Patent Application Concerning Treatment of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin Complexes, 9103 [E8-2980]

Download as PDF Federal Register / Vol. 73, No. 33 / Tuesday, February 19, 2008 / Notices DEPARTMENT OF DEFENSE DEPARTMENT OF DEFENSE Department of the Army Department of the Army; Corps of Engineers Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of Invention Described in U.S. Provisional Patent Application Concerning Treatment of IschemiaReperfusion Injury with Lipid, Annexin, and Lipid-Annexin Complexes AGENCY: ACTION: Department of the Army, DoD. Notice. SUMMARY: In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement is made of the availability for licensing of the invention described in U.S. Provisional Patent Application No. 60/ 786,527 entitled ‘‘Treatment of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin Complexes,’’ filed March 27, 2006. Foreign rights are also available (PCT/ US2007/065125). The United States Government, as represented by the Secretary of the Army, has rights in this invention. Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–ZA–J, 504 Scott Street, Fort Detrick, Frederick, MD 21702–5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: Disclosed are lipids, annexin, and lipid-annexin complexes for use in the prevention and/or treatment of ischemiareperfusion injury and reperfusion injury associated with a variety of diseases and conditions. Also disclosed are therapeutic targets and compositions for the prevention and treatment of ischemia-reperfusion injury and diseases and conditions associated with ischemia-reperfusion injury. SUPPLEMENTARY INFORMATION: mstockstill on PROD1PC66 with NOTICES Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. E8–2980 Filed 2–15–08; 8:45 am] BILLING CODE 3710–08–P VerDate Aug<31>2005 16:52 Feb 15, 2008 Jkt 214001 Notice of Intent To Prepare a Draft Environmental Impact Statement on Rock Mining in Wetlands in Levy County, FL Department of the Army, U.S. Army Corps of Engineers, DoD. ACTION: Notice of intent. AGENCY: SUMMARY: The U.S. Army Corps of Engineers (Corps) Jacksonville District intends to prepare a Draft Environmental Impact Statement (DEIS), referred to as the Tarmac King Road Limestone Mine DEIS, to evaluate potential impacts of rock mining within wetlands in southern Levy County, FL. DATES: The Corps plans to hold two public scoping meetings on or about March 26 and 27, 2008 at 6 p.m. EST. ADDRESSES: The first meeting will be held on March 26, 2008 at the Inglis Community Center, 137 Highway 40 West, Inglis, FL 34449, (352) 447–2203. The second meeting will be held March 27, 2008 at the Tommy Usher Community Center, 506 Southwest 4th Avenue, Chiefland, FL 32626–0121, (352) 493–6711. FOR FURTHER INFORMATION CONTACT: Mr. Edward P. Sarfert, (850) 439–9533 or e-mail at edward.p.sarfert@usace.army.mil. SUPPLEMENTARY INFORMATION: a. Background/Project Authorization. The Corps is preparing this DEIS in accordance with the National Environmental Policy Act (NEPA) of 1969 (42 U.S.C. 4321 et seq.), Council of on Environmental Quality (CEQ) Regulations (40 CFR 1500 et seq.), and Corps provisions for implementing the procedural requirements of NEPA (33 CFR 230, USACE Engineering Regulation ER 200–2–2). A primary purpose of a Corps Regulatory Program EIS is to provide full and fair discussion of the significant environmental impacts of a proposal or project seeking a U.S. Department of Army permit. The Draft and Final EIS are used to inform the public and agency decision-makers of alternatives to an applicant’s project that might avoid or minimize adverse impacts or enhance the quality of the human environment. An EIS is not a Corps regulatory decision document. It is used by agency officials in conjunction with other relevant information in a permit application file, including public and agency comments presented in the Final EIS, to support the final decision on a permit PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 9103 application. In this instance, Tarmac America, LLC, has filed a permit application to mine areas that include wetlands within Levy County, FL. b. Need or Purpose. The purpose of the proposed action is to provide construction-grade aggregate that meets the Florida Department of Transportation specifications for buildings and infrastructure. The proposed mine is to provide this aggregate for Tarmac’s and its customers’ use in the west central area of Florida. The Corps recognizes that there is a public and private need for this product. The purpose of the proposed DEIS is to evaluate the environmental effects of alternatives to meet these requirements while protecting the aquatic environment. c. Prior EAs, EISs. None. d. Alternatives. An evaluation of alternatives, including a No Action alternative and rock mining in other areas both inside and outside of Levy County and/or Florida will be done. The DEIS will analyze reasonable alternatives to obtaining construction grade limestone to meet the purpose and need. Alternatives will be determined through scoping, but are expected to vary according to timing, and breadth of mining, in addition to a ‘‘no action’’ alternative. e. Issues. The following issues have been identified for analysis in the DEIS. This list is preliminary and is intended to facilitate public comment on the scope of the DEIS. The DEIS will consider the effects on Federally listed threatened and endangered species, health and safety, socioeconomics, aesthetics, general environmental concerns, wetlands (and other aquatic resources), historic properties, cultural resources, fish and wildlife values, land use, transportation, recreation, water supply and conservation, water quality, energy needs, mineral needs, considerations of property ownership, and, in general, the needs and welfare of the people, and other issues identified through scoping, public involvement, and interagency coordination. At the present time, our primary areas of environmental concern are the loss of wetland functions and value, mitigation of such losses, and the effect of proposed mining on groundwater and surface water quality and on transportation. We expect to better define the issues of concern and define the methods that will be used to evaluate those issues through the scoping process. f. Scoping Process. CEQ regulations (40 CFR 1501.7) require an early and open process for determining the scope of a DEIS and for identifying significant E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 73, Number 33 (Tuesday, February 19, 2008)]
[Notices]
[Page 9103]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-2980]



[[Page 9103]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of Invention Described in U.S. Provisional Patent Application 
Concerning Treatment of Ischemia-Reperfusion Injury with Lipid, 
Annexin, and Lipid-Annexin Complexes

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.4, 404.6 and 404.7, announcement 
is made of the availability for licensing of the invention described in 
U.S. Provisional Patent Application No. 60/786,527 entitled ``Treatment 
of Ischemia-Reperfusion Injury with Lipid, Annexin, and Lipid-Annexin 
Complexes,'' filed March 27, 2006. Foreign rights are also available 
(PCT/US2007/065125). The United States Government, as represented by 
the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Disclosed are lipids, annexin, and lipid-
annexin complexes for use in the prevention and/or treatment of 
ischemia-reperfusion injury and reperfusion injury associated with a 
variety of diseases and conditions. Also disclosed are therapeutic 
targets and compositions for the prevention and treatment of ischemia-
reperfusion injury and diseases and conditions associated with 
ischemia-reperfusion injury.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
 [FR Doc. E8-2980 Filed 2-15-08; 8:45 am]
BILLING CODE 3710-08-P